MEGAN DELA REA: Open Payments
NPI 1154942571 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$813 in 45 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $419 · 2025 $813
Food & beverage: $813
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $87 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| Novo Nordisk Inc | 4 | $77 |
| Lilly USA, LLC | 4 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Astellas Pharma US Inc | 4 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| Noven Therapeutics, LLC | 3 | $50 |
| Exact Sciences Corporation | 2 | $48 |
| Phathom Pharmaceuticals, Inc. | 3 | $45 |
Products named: INJECTAFER, MOUNJARO, XIFAXAN, Veozah, AIRSUPRA, Kerendia, Xelstrym, Cologuard Collection Kit.
Industry payments across FL — which companies pay providers there.
